Key result
Silencing SOCS-1 and SOCS-3 suppresses renal fibrosis by alleviating tubular damage in hydronephrotic rats.
Why the study?
Does silencing of SOCS-1 and SOCS-3 reduce renal interstitial fibrosis and tubular damage in a rat model of hydronephrosis?
Does silencing of SOCS-1 and SOCS-3 reduce renal interstitial fibrosis and tubular damage in a rat model of hydronephrosis?
Silencing of SOCS-1 and SOCS-3 suppresses renal interstitial fibrosis and alleviates renal tubular damage in a rat model of hydronephrosis.
Should not yet change practice in hydronephrosis; hypothesis-generating for SOCS-1/3 as antifibrotic targets.
Our study was performed to elucidate how SOCS-1/3 silencing suppresses renal interstitial fibrosis (RIF) by alleviating renal tubular damage in rat models affected by hydronephrosis. Male Wistar rats were randomly selected to establish hydronephrosis rat model, after which all rats were classified into normal, model, negative control (NC), siRNA-SOCS-1, siRNA-SOCS-3, and siRNA-SOCS-1 + siRNA-SOCS-3 groups. The levels of urine protein, serum creatinine (Scr), and blood urea nitrogen (BUN) were detected. ELISA was performed to determine levels of cystatin (CysC), β2-microglobulin (β2-MG), interleukin (IL)-6, and tumor necrosis factor (TNF)-α. RT-qPCR and Western blotting were used for mRNA and protein expressions of SOCS-1, SOCS-3, α-smooth muscle actin (α-SMA), and transforming Growth Factor (TGF)-β1. Compared with the normal group, the levels of Scr, BUN, urine protein, NAG, CysC, β2-MG, IL-6, and TNF-α were increased in other groups, as well as elevated mRNA and protein expressions of SOCS-1, SOCS-3, α-SMA, and TGF-β1. The siRNA-SOCS-1, siRNA-SOCS-3, and siRNA-SOCS-1 + siRNA-SOCS-3 groups were found with decreased levels of Scr, BUN, urine protein, NAG, CysC, β2-MG, IL-6, and TNF-α, as well as mRNA and protein expressions of SOCS-1, SOCS-3, α-SMA, and TGF-β1, including positive rates of SOCS-1 and SOCS-3 proteins in comparison with the model and NC groups. In comparison with the siRNA-SOCS-1 and siRNA-SOCS-3 groups, the siRNA-SOCS-1 + siRNA-SOCS-3 group exhibited decreased levels of Scr, BUN, urine protein, NAG, CysC, β2-MG, IL-6, and TNF-α. Our study demonstrated that silencing of SOCS-1/3 may suppress RIF by alleviating the renal tubular damage in rat models affected by hydronephrosis.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2017) studied Hydronephrosis. Silencing of SOCS-1 and SOCS-3 (siRNA-SOCS-1 and/or siRNA-SOCS-3) vs. Model and negative control groups was evaluated on Levels of Scr, BUN, urine protein, NAG, CysC, β2-MG, IL-6, TNF-α, and fibrosis markers. Silencing of SOCS-1 and SOCS-3 suppressed renal interstitial fibrosis by alleviating renal tubular damage in a rat model of hydronephrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: